[PDF][PDF] GESTIONE DEL PAZIENTE CHIRURGICO D'URGENZA E DEL TRAUMATIZZATO IN TERAPIA CON NUOVI ANTICOAGULANTI ORALI (NAO).
S Cimbanassi, O Chiara - sicut.net
I nuovi anticoagulanti orali (NAO), introdotti per la profilassi e il trattamento della
tromboembolia e dello stroke nei pazienti affetti da fibrillazione atriale non valvolare …
tromboembolia e dello stroke nei pazienti affetti da fibrillazione atriale non valvolare …
[HTML][HTML] Modernes Thrombosemanagement
K Tsagoudis, R Ostendorf - Aktuelle Dermatologie, 2015 - thieme-connect.com
Die Kombination aus D-Dimer-Test und den klinischen Zeichen des Wells-Scores ist, wie
eine große Metaanalyse erneut belegt, bei nicht onkologischen Patienten ausreichend, um …
eine große Metaanalyse erneut belegt, bei nicht onkologischen Patienten ausreichend, um …
Deep Vein Thrombosis and Pulmonary Embolism in the Apixaban Era: From Bench to Bedside
P Poredos, MK Jezovnik - Current Drug Targets, 2018 - ingentaconnect.com
Background: The traditional treatment of venous thromboembolism (VTE) with heparin and
warfarin has numerous limitations. New oral anticoagulants represent the promising …
warfarin has numerous limitations. New oral anticoagulants represent the promising …
Novel Oral Anticoagulants for Thromboprophylaxis in Non-Valvular Atrial Fibrillation: Focus on Randomized Clinical Trials
TS Potpara, MM Polovina, MM Licina… - Frontiers in …, 2015 - books.google.com
Stroke prevention in atrial fibrillation (AF) has been challenging over decades, mostly due to
a number of difficulties associated with oral vitamin K antagonists (VKAs), which were the …
a number of difficulties associated with oral vitamin K antagonists (VKAs), which were the …
[PDF][PDF] The Study of the Mechanism of Action of the Newly Synthesized Direct Anticoagulant of Thiazoline Ammonium-4-Chlorophenyl-2-Hydroxy-4-Oxo-2-Butenoate
AV Starkova, BY Syropyatov, FV Sobin… - Int J Blood Res …, 2015 - scholar.archive.org
The aim of this research is to study the mechanism of action of the newly synthesized
substance-Thiazoline Ammonium 4-Chlorophenyl-2-Hydroxy-4-Oxo-2-Butenoate (FS-169) …
substance-Thiazoline Ammonium 4-Chlorophenyl-2-Hydroxy-4-Oxo-2-Butenoate (FS-169) …
Oral anticoagulants and clinical decision making for stroke prevention in non-valvular atrial fibrillation for nurse practitioners
RB Queiroz - 2014 - unbc.arcabc.ca
This literature review explored the question of which oral anticoagulant offers the best
efficacy and safety for stroke prevention in non-valvular atrial fibrillation and how the nurse …
efficacy and safety for stroke prevention in non-valvular atrial fibrillation and how the nurse …
Thrombogenesis in substrates of atrial fibrillation
CD Schultz - 2014 - hekyll.services.adelaide.edu.au
Background: Atrial Fibrillation (AF) is the most common atrial arrhythmia affecting Australia
and the world, with patients with AF known to be at a 5times higher risk of stroke than that of …
and the world, with patients with AF known to be at a 5times higher risk of stroke than that of …
[PDF][PDF] Target Audience
J Providership - 2020 - kassmd.org
This activity has been planned and implemented in accordance with the Essential Areas and
Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the …
Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the …
[引用][C] How do antiplatelets and anticoagulants affect extraction?
S Sohal - BDJ Student, 2022 - nature.com
Ask the patient to check their INR. The INR reading must NOT be more than 72 hours for a
stable patient but ideally within 24 hours. If the INR< 4 then extract a single tooth and …
stable patient but ideally within 24 hours. If the INR< 4 then extract a single tooth and …